Addition of sitagliptin to ongoing metformin improved metabolic profile and pancreatic function via normalizing inflammatory cytokines' levels in patients with type 2 diabetes, a randomized double-blinded clinical trial
{{output}}
Background: DPP-4 inhibitors have anti-diabetic effects in T2DM, but their impact on pancreatic function and underlying mechanisms remain unclear. This study aimed to evaluate the effects of sitagliptin on pancreatic function and... ...
